Signant SmartSignals eCOA for Advanced Breast Cancer

A top pharmaceutical company wanted to conduct a prospective, multi-site, observational study to better understand how their treatment and treatment-related adverse events (AEs) impact daily life for advanced breast cancer patients.

Read our case study to learn how Signant’s eCOA solution helped collect accurate data from patients in a remote setting.

For a demo or presentation on our eCOA, please contact our team.